Decision Makers Roundtable – Business AI for Pharma

An exclusive, invite-only (max 10 seats) roundtable for senior decision-makers in pharma and life sciences exploring how AI is reshaping the foundations of pharmaceutical organizations.
Hosted by Bertram Weiss at the Merantix AI Campus in Berlin.
This is a highly curated, closed-door session for a maximum of 10 VIP decision-makers, designed for real exchange rather than presentations. Breakfast, coffee, and refreshments will be provided throughout the session.
Theme
Business AI for Pharma: From Efficiency Gains to AI-First Operating Models
Pharma is moving beyond isolated AI use cases. The real shift is no longer about where AI can optimize processes, but how organizations need to fundamentally evolve to become AI-native.
This roundtable explores how pharmaceutical companies can rethink processes, decision-making, and operating models in an AI-driven world — and how European pharma can position itself in a rapidly evolving AI landscape.
What we will discuss
We will focus on practical, strategic questions such as:
 How to move from AI tools to AI-first operating models
 Why efficiency gains alone are no longer sufficient
 How AI is changing core pharma workflows and decision-making
 What organizational readiness and governance actually require
 How pharma can stay competitive in an AI-driven global ecosystem
Agenda
09:30 – 10:00 | Arrival & Networking
Breakfast, coffee, and informal introductions
10:00 – 10:15 | Opening & Framing
Host introduction and context-setting: AI-first pharma and operating model transformation
10:15 – 10:45 | Expert Input
From efficiency gains to real transformation — what AI changes in pharma organizations
10:45 – 11:30 | Roundtable Discussion
Moderated peer exchange on AI-first operating models, scaling challenges, and strategic positioning
11:30 – 11:45 | Key Takeaways
Synthesis of key insights, patterns, and perspectives from the discussion
11:45 – 12:00 | Networking & Closing
Open exchange and follow-up conversations
Format
 Invite-only session
 Maximum 10 senior decision-makers
 Closed-door roundtable format
 No recordings, no external distribution
Why attend
This roundtable is designed for senior leaders who want to move beyond experimentation and actively shape how their organizations operate in an AI-first future.
It offers a rare opportunity for a focused peer exchange in an intimate setting with decision-makers facing the same transformation challenges and our AI-first engineering expertise here at Merantix Momentum.
About Your Hosts
Bertram Weiss - VP Health & Pharma, Merantix Momentum
Bertram brings over 25 years of experience across global pharmaceutical R&D and IT, with a strong focus on translating data into real impact in drug discovery and patient outcomes. With a scientific background in chemistry, biology, and biochemistry, he combines deep domain expertise with a passion for building computational solutions that address unmet needs in healthcare.
He is known for bridging the gap between business and technology, aligning drug discovery with data science to drive measurable value. Bertram is also an experienced communicator, engaging stakeholders across boards, partners, and the broader ecosystem.
Thomas Wollmann - Managing Director / CTO, Merantix Momentum
Dr. Thomas Wollmann is an expert in machine learning and AI infrastructure, with over a decade of experience in computer vision and applied AI. He holds a PhD in computer science and a Master’s degree in medical informatics from Heidelberg University, where his research focused on high-content microscopy image analysis.
Thomas combines deep technical expertise with a strong focus on building scalable, production-ready AI systems, helping organizations move from experimentation to real-world deployment.